Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer
- 51 Downloads
We aimed to investigate the impact of postoperative weight loss following radical cystectomy (RC) on patients’ prognoses. RC and urinary diversion were performed in 512 consecutive patients with muscle-invasive bladder cancer at our hospitals between May 1996 and July 2018. Demographic clinical information, pre- and postoperative serum albumin, hemoglobin, and weight were evaluated retrospectively at 1 month. We also evaluated the association of weight loss with complications and overall survival (OS) as estimated using the Kaplan–Meier method and compared using the log-rank test. Risk factors for poor OS were determined by Inverse Probability of Treatment Weighted (IPTW)-adjusted Cox regression analysis. In 385 patients who met the study search criteria, median postoperative weight loss from baseline at 1 week and 1 month was 1.1 (− 1.8%) and 3.2 (− 5.4%) kg, respectively. Patients with significant weight loss (defined as ≥ 7.5% at 1 month) had higher-grade complications within 1 month and had significantly shorter OS than those with weight loss of < 7.5%. Type of urinary diversion, loss of serum albumin, and loss of hemoglobin were not significantly associated with weight loss. IPTW-adjusted Cox regression analysis showed that such significant weight loss was an independent risk factor for poor OS. Weight loss followed by radical cystectomy was significantly associated with poor prognosis in patients with muscle-invasive bladder cancer.
KeywordsCystectomy Weight loss Frailty Survival Bladder cancer
The authors would like to thank Teppei Okamoto, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hiromichi Iwamura, Takuma Narita, Yuki Fujita, Yukie Nishizawa, and Satomi Sakamoto for their invaluable support with data collection. The authors would also like to thank Enago (http://www.enago.jp) for English language review.
This work was supported by a Grant-in-Aid for Scientific Research (Grant Nos. 15H02563, 15K15579, 17K11118, 17K11119, 17K16768, 17K16770, 17K16771, 18K16681, 18K16682, 18K16717, 18K16718, 18K16719, and 18K09157) from the Japan Society for the Promotion of Science.
Compliance with ethical standards
Conflict of interest
The authors have no conflict of interest.
- 3.Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Kudoh S, Yoneyama T, et al. Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution. Eur J Surg Oncol. 2012;38(11):1101–5. https://doi.org/10.1016/j.ejso.2012.07.115.CrossRefPubMedGoogle Scholar
- 5.Koie T, Ohyama C, Yoneyama T, Nagasaka H, Yamamoto H, Imai A, et al. Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes. Int J Med Robot. 2018:e1955. https://doi.org/10.1002/rcs.1955.
- 8.Vidal A, Arnold N, Vartolomei MD, Kiss B, Burkhard F, Thalmann GN, et al. Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: a single-center randomized trial. Int J Urol. 2016;23(12):992–9. https://doi.org/10.1111/iju.13228.CrossRefPubMedGoogle Scholar
- 13.Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, et al. Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers. Oncotarget. 2018;9(25). https://doi.org/10.18632/oncotarget.24712.
- 15.Momota M, Hatakeyama S, Tokui N, Sato T, Yamamoto H, Tobisawa Y, et al. The impact of preoperative severe renal insufficiency on poor postsurgical oncological prognosis in patients with urothelial carcinoma. Eur Urol Focus. 2018. https://doi.org/10.1016/j.euf.2018.03.003.CrossRefPubMedGoogle Scholar
- 16.Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, et al. Impact of bacillus Calmette–Guerin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy. Med Oncol. 2018;35(4):41. https://doi.org/10.1007/s12032-018-1102-y.CrossRefPubMedGoogle Scholar
- 18.Koie T, Ohyama C, Hashimoto Y, Hatakeyama S, Yamamoto H, Yoneyama T, et al. Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study. Int J Clin Oncol. 2013;18(4):724–30. https://doi.org/10.1007/s10147-012-0447-z.CrossRefPubMedGoogle Scholar
- 19.Anan G, Hatakeyama S, Fujita N, Iwamura H, Tanaka T, Yamamoto H, et al. Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study. Oncotarget. 2017;8(49):86130–42. https://doi.org/10.18632/oncotarget.20991.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, et al. Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer. Med Oncol. 2014;31(5):949. https://doi.org/10.1007/s12032-014-0949-9.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, et al. Slow gait speed and rapid renal function decline are risk factors for postoperative delirium after urological surgery. PLoS ONE. 2016;11(5):e0153961. https://doi.org/10.1371/journal.pone.0153961.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Rammant E, Decaestecker K, Bultijnck R, Sundahl N, Ost P, Pauwels NS, et al. A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy. Clin Rehabil. 2018;32(5):594–606. https://doi.org/10.1177/0269215517746472.CrossRefPubMedGoogle Scholar